Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are established therapies in chronic kidney disease (CKD), but comparative data in kidney transplant recipients (KTR) remain limited. Methods We retrospectively matched 100 KTR receiving SGLT2i to 100 controls not receiving SGLT2i and assessed body mass inde...
Lino Henkel, Lisa Ingmanns, F. Westphal et al.· Frontiers in Transplantation· 0 citations
LLMs have high diagnostic accuracy when challenged with published nephrological case scenarios, and the interpretation is limited, however, because previous exposure of the models to individual vignettes, or parts thereof, cannot be ruled out.
Chalid Hasan, Göran R. Boeckel, S. Siam et al.· Deutsches Ärzteblatt Interna...· 0 citations
The findings uncover a novel product-inhibition mechanism that limits INF2 function and offer important insight into disease mechanisms linked to actin dysregulation.
Felix Uecker, Sven Wargenau, Micaela Boiero Sanders et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.